Skip to content

Comparison of two recombinant follicle-stimulating hormone for ovarian stimulation

Comparison of two recombinant follicle-stimulating hormone preparations for ovarian stimulation in gonadotropin releasing hormone antagonist protocol: A randomized clinical study - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085629
Enrollment
300
Registered
2025-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N979- Female infertility, unspecified

Interventions

Intervention1: Gonal F: The enrolled patients will undergo controlled ovarian stimulation with GnRH antagonist protocol. Medications in each group will be administered with GnRH-antagonists as per Fle

Sponsors

Jabacsmick Sharmila
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: POSEIDON group 1 BMI 18 to 30 First or second cycle in the present series of assisted reproduction techniques. Unexplained infertility Dysovulatory infertility Tubal factor infertility Normal male factor or Mild OAT

Exclusion criteria

Exclusion criteria: Gonadotropin releasing hormone agonist protocol Endometriosis grade 3 and 4 History of more than two earlier assisted reproduction technique retrieval cycles Presence of endocrine disorder Known tumours of the hypothalamus and pituitary gland, or both History of poor response to gonadotrophin treatment (defined as fewer than five oocytes retrieved in a previous attempt) SOAT(less than 1M), Necrozoospermia

Design outcomes

Primary

MeasureTime frame
To compare the number of oocytes retrieved, FOI, FORT, percentage of mature oocytes (Oocyte maturity rate) between two groupsTimepoint: 20 days

Secondary

MeasureTime frame
To compare the total number of days of stimulation, fertilisation rate, blastocyst development rate and incidence of moderate or severe ovarian hyperstimulation syndrome.Timepoint: 20 days

Countries

India

Contacts

Public ContactJabacsmick Sharmila

A4 Hospitals and Fertility centre Pvt Ltd

researchccordinator@a4fertility.com9790864544

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026